⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23883123 | 1.00 | — | — | |
| SCHEMBL23883118 | 0.81 | — | — | |
| SCHEMBL23880595 | 0.81 | — | — | |
| SCHEMBL12807540 | 0.80 | ALDH1A1 (0.33) | — | |
| SCHEMBL17030194 | 0.78 | — | — | |
| SCHEMBL8820593 | 0.77 | — | — | |
| SCHEMBL1494084 | 0.77 | — | — | |
| SCHEMBL1494080 | 0.77 | — | — | |
| SCHEMBL9957011 | 0.77 | — | — | |
| SCHEMBL8820319 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 117 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110183913-A1 | NOVEL LIPID DIPEPTIDE AND GEL | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2011-07-28 | — | — | US | claimed |
| EP-2319894-A1 | NOVEL LIPID DIPEPTIDE AND GEL | Nissan Chemical Industries, Ltd. (JP) | 2011-05-11 | — | — | EP | claimed |
| US-6251854-B1 | COMPRISING AN OLIGOPETIDE INCLUDING A GUANIDINIUM-CONTAINING AMINO ACID SUCH AS ARGININE, AND A COMPOUND SUCH AS 2H-3-(4-FLUOROBENZYL)-7-(BUT-2-YL)-8-(3-METHYLBUTYL)-DIAZOLIDINE(1,2 -B)DIHYDROIMIDAZOLE | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2001-06-26 | — | — | US | claimed |
| WO-1998041223-A1 | N-METHYL-D-ASPARTATE RECEPTOR CHANNEL BLOCKERS AND METHOD FOR IDENTIFYING SUCH | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1998-09-24 | — | — | WO | claimed |
| US-20240132628-A1 | OLIGONUCLEOTIDE ANALOGUE THERAPEUTICS FOR TREATMENT OF NEUROMUSCULAR DISEASE | NEUBASE THERAPEUTICS, INC. | 2024-04-25 | — | — | US | disclosed |
| US-20230404888-A1 | COMPOSITION CONTAINING LIPID PEPTIDE AND SUCROSE ESTER | NISSAN CHEMICAL CORPORATION (JP) | 2023-12-21 | — | — | US | disclosed |
| US-11771645-B2 | Transdermally absorbable base material containing lipid peptide compound | KYUSHU UNIVERSITY (JP) | 2023-10-03 | — | — | US | disclosed |
| CN-116744892-A | Compositions comprising a lipid peptide and a sucrose ester | 日产化学株式会社 | 2023-09-12 | — | — | CN | disclosed |
| EP-4230265-A1 | COMPOSITION CONTAINING LIPID PEPTIDE AND SUCROSE ESTER | Nissan Chemical Corporation (JP) | 2023-08-23 | — | — | EP | disclosed |
| EP-3251656-B1 | MOISTURIZING BASE MATERIAL INCLUDING LIPID-PEPTIDE COMPOUND | UNIV KYUSHU (JP) | 2023-07-05 | — | — | EP | disclosed |
| US-11603530-B2 | Modified peptide nucleic acid compositions | NEUBASE THERAPEUTICS, INC. (US) | 2023-03-14 | — | — | US | disclosed |
| US-20230062111-A1 | ANTI-POLLUTION MATERIAL | NISSAN CHEMICAL CORPORATION (JP) | 2023-03-02 | — | — | US | disclosed |
| US-20130267610-A1 | NOVEL LIPID DIPEPTIDE AND GEL | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2013-10-10 | — | — | US | disclosed |
| US-20130267609-A1 | NOVEL LIPID DIPEPTIDE AND GEL | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2013-10-10 | — | — | US | disclosed |
| US-20120035108-A1 | SPRAY BASE MATERIAL INCLUDING LOW-MOLECULAR GELATOR | KYUSHU UNIVERSITY (JP) | 2012-02-09 | — | — | US | disclosed |
| EP-2410031-A1 | BASE MATERIAL FOR SPRAYING COMPRISING LOW-MOLECULAR GELLING AGENT | Nissan Chemical Industries, Ltd. (JP) | 2012-01-25 | — | — | EP | disclosed |
| US-20110183913-A1 | NOVEL LIPID DIPEPTIDE AND GEL | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2011-07-28 | — | — | US | disclosed |
| EP-2319894-A1 | NOVEL LIPID DIPEPTIDE AND GEL | Nissan Chemical Industries, Ltd. (JP) | 2011-05-11 | — | — | EP | disclosed |
| US-6251854-B1 | COMPRISING AN OLIGOPETIDE INCLUDING A GUANIDINIUM-CONTAINING AMINO ACID SUCH AS ARGININE, AND A COMPOUND SUCH AS 2H-3-(4-FLUOROBENZYL)-7-(BUT-2-YL)-8-(3-METHYLBUTYL)-DIAZOLIDINE(1,2 -B)DIHYDROIMIDAZOLE | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2001-06-26 | — | — | US | disclosed |
| WO-1998041223-A1 | N-METHYL-D-ASPARTATE RECEPTOR CHANNEL BLOCKERS AND METHOD FOR IDENTIFYING SUCH | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1998-09-24 | — | — | WO | disclosed |